Pharmagest Interactive SA
F:PHF
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
39.15
65.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Pharmagest Interactive SA
Pharmagest Interactive SA
Current Portion of Long-Term Debt
Pharmagest Interactive SA
Current Portion of Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharmagest Interactive SA
F:PHF
|
Current Portion of Long-Term Debt
€22.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
44%
|
|
|
Cegedim SA
PAR:CGM
|
Current Portion of Long-Term Debt
€76.2m
|
CAGR 3-Years
54%
|
CAGR 5-Years
31%
|
CAGR 10-Years
21%
|
|
|
Equasens SA
PAR:EQS
|
Current Portion of Long-Term Debt
€22.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
44%
|
|
|
Median Technologies SA
PAR:ALMDT
|
Current Portion of Long-Term Debt
€19.5m
|
CAGR 3-Years
285%
|
CAGR 5-Years
130%
|
CAGR 10-Years
22%
|
|
Pharmagest Interactive SA
Glance View
Pharmagest Interactive SA engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. The company operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
See Also
What is Pharmagest Interactive SA's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
22.3m
EUR
Based on the financial report for Dec 31, 2023, Pharmagest Interactive SA's Current Portion of Long-Term Debt amounts to 22.3m EUR.
What is Pharmagest Interactive SA's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
44%
Over the last year, the Current Portion of Long-Term Debt growth was 24%. The average annual Current Portion of Long-Term Debt growth rates for Pharmagest Interactive SA have been 10% over the past three years , 34% over the past five years , and 44% over the past ten years .
You don't have any saved screeners yet
